Biomarkers Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global biomarkers market is expected to grow at a CAGR of around 11.5% during 2025-2034. This report on global biomarkers market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global biomarkers market by segmenting the market based on product, application, indication and region. Also, detailed profiles of companies operating in the biomarkers market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Increasing Application in Drug Discovery
Market Challenges
• Stringent Regulations
Historical & Forecast Period
Base Year: 2024 Historical Period: 2020-2024 Forecast Period: 2025-2034
Market by Type
• Safety • Efficacy • Validation
Market by Application
• Diagnostics • Drug discovery & development • Personalized Medicine • Other Applications
Market by Indication
• Oncology • Cardiology • Neurology • Other
Market by Region
• Europe Germany United Kingdom France Italy Spain Russia Netherlands Rest of Europe • North America United States Canada • Asia Pacific China Japan India South Korea Australia Indonesia Rest of Asia Pacific • Latin America Mexico Brazil Argentina Rest of Latin America • Middle East & Africa Saudi Arabia Turkey Iran United Arab Emirates Rest of Middle East & Africa
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Biomarkers Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Biomarkers Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Biomarkers Market by Type
5.1. Introduction
5.2. Safety
5.3. Efficacy
5.4. Validation
6. Global Biomarkers Market by Application
6.1. Introduction
6.2. Diagnostics
6.3. Drug discovery & development
6.4. Personalized Medicine
6.5. Other Applications
7. Global Biomarkers Market by Indication
7.1. Introduction
7.2. Oncology
7.3. Cardiology
7.4. Neurology
7.5. Other
8. Global Biomarkers Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Abbott
12.2.2. Axon Medchem
12.2.3. Bio-Rad Laboratories, Inc.
12.2.4. BioVision Inc.
12.2.5. Epigenomics AG
12.2.6. F. Hoffmann-La Roche Ltd.
12.2.7. General Electric
12.2.8. Johnson & Johnson Services, Inc.
12.2.9. Myriad RBM.
12.2.10. QIAGEN
12.2.11. R&D System
12.2.12. Siemens Healthcare GmbH
12.2.13. Sino Biological Inc.
12.2.14. Thermo Fisher Scientific Inc.
List of Figures
Figure 1: Global Biomarkers Market (in US$ Million), 2020-2024
Figure 2: Global Biomarkers Market by Type, 2024
Figure 3: Global Biomarkers Market by Application, 2024
Figure 4: Global Biomarkers Market by Indication, 2024
Figure 5: Global Biomarkers Market by Region, 2024
Figure 6: Global Biomarkers Market (in US$ Million), 2025-2034
Figure 7: Global Biomarkers Market by Type (in %), 2024 & 2034
Figure 8: Global Safety Biomarkers Market (in US$ Million), 2020-2024
Figure 9: Global Safety Biomarkers Market (in US$ Million), 2025-2034
Figure 10: Global Efficacy Biomarkers Market (in US$ Million), 2020-2024
Figure 11: Global Efficacy Biomarkers Market (in US$ Million), 2025-2034
Figure 12: Global Validation Biomarkers Market (in US$ Million), 2020-2024
Figure 13: Global Validation Biomarkers Market (in US$ Million), 2025-2034
Figure 14: Global Biomarkers Market by Application (in %), 2024 & 2034
Figure 15: Global Diagnostics Biomarkers Market (in US$ Million), 2020-2024
Figure 16: Global Diagnostics Biomarkers Market (in US$ Million), 2025-2034
Figure 17: Global Drug Discovery & Development Biomarkers Market (in US$ Million), 2020-2024
Figure 18: Global Drug Discovery & Development Biomarkers Market (in US$ Million), 2025-2034
Figure 19: Global Personalized Medicine Biomarkers Market (in US$ Million), 2020-2024
Figure 20: Global Personalized Medicine Biomarkers Market (in US$ Million), 2025-2034
Figure 21: Global Other Applications Medicine Biomarkers Market (in US$ Million), 2020-2024
Figure 22: Global Other Applications Medicine Biomarkers Market (in US$ Million), 2025-2034
Figure 23: Global Biomarkers Market by Indication (in %), 2024 & 2034
Figure 24: Global Oncology Biomarkers Market (in US$ Million), 2020-2024
Figure 25: Global Oncology Biomarkers Market (in US$ Million), 2025-2034
Figure 26: Global Cardiology Biomarkers Market (in US$ Million), 2020-2024
Figure 27: Global Cardiology Biomarkers Market (in US$ Million), 2025-2034
Figure 28: Global Neurology Biomarkers Market (in US$ Million), 2020-2024
Figure 29: Global Neurology Biomarkers Market (in US$ Million), 2025-2034
Figure 30: Global Other Indications Biomarkers Market (in US$ Million), 2020-2024
Figure 31: Global Other Indications Biomarkers Market (in US$ Million), 2025-2034
Figure 32: Global Biomarkers Market by Region (in %), 2024 & 2034
Figure 33: Europe Biomarkers Market (in US$ Million), 2020-2024
Figure 34: Europe Biomarkers Market (in US$ Million), 2025-2034
Figure 35: Europe Biomarkers Market by Country (in %), 2024 & 2034
Figure 36: Germany Biomarkers Market (in US$ Million), 2020-2034
Figure 37: United Kingdom Biomarkers Market (in US$ Million), 2020-2034
Figure 38: France Biomarkers Market (in US$ Million), 2020-2034
Figure 39: Italy Biomarkers Market (in US$ Million), 2020-2034
Figure 40: Spain Biomarkers Market (in US$ Million), 2020-2034
Figure 41: Russia Biomarkers Market (in US$ Million), 2020-2034
Figure 42: Netherlands Biomarkers Market (in US$ Million), 2020-2034
Figure 43: North America Biomarkers Market (in US$ Million), 2020-2024
Figure 44: North America Biomarkers Market (in US$ Million), 2025-2034
Figure 45: North America Biomarkers Market by Country (in %), 2024 & 2034
Figure 46: United States Biomarkers Market (in US$ Million), 2020-2034
Figure 47: Canada Biomarkers Market (in US$ Million), 2020-2034
Figure 48: Asia Pacific Biomarkers Market (in US$ Million), 2020-2024
Figure 49: Asia Pacific Biomarkers Market (in US$ Million), 2025-2034
Figure 50: Asia Pacific Biomarkers Market by Country (in %), 2024 & 2034
Figure 51: China Biomarkers Market (in US$ Million), 2020-2034
Figure 52: Japan Biomarkers Market (in US$ Million), 2020-2034
Figure 53: India Biomarkers Market (in US$ Million), 2020-2034
Figure 54: South Korea Biomarkers Market (in US$ Million), 2020-2034
Figure 55: Australia Biomarkers Market (in US$ Million), 2020-2034
Figure 56: Indonesia Biomarkers Market (in US$ Million), 2020-2034
Figure 57: Latin America Biomarkers Market (in US$ Million), 2020-2024
Figure 58: Latin America Biomarkers Market (in US$ Million), 2025-2034
Figure 59: Latin America Biomarkers Market by Country (in %), 2024 & 2034
Figure 60: Mexico Biomarkers Market (in US$ Million), 2020-2034
Figure 61: Brazil Biomarkers Market (in US$ Million), 2020-2034
Figure 62: Argentina Biomarkers Market (in US$ Million), 2020-2034
Figure 63: Middle East & Africa Biomarkers Market (in US$ Million), 2020-2024
Figure 64: Middle East & Africa Biomarkers Market (in US$ Million), 2025-2034
Figure 65: Middle East & Africa Biomarkers Market by Country (in %), 2024 & 2034
Figure 66: Saudi Arabia Biomarkers Market (in US$ Million), 2020-2034
Figure 67: Turkey Biomarkers Market (in US$ Million), 2020-2034
Figure 68: Iran Biomarkers Market (in US$ Million), 2020-2034
Figure 69: UAE Biomarkers Market (in US$ Million), 2020-2034
Figure 70: Market Value Chain
List of Tables
Table 1: Global Biomarkers Market Portraiture
Table 2: Global Biomarkers Market by Type (in US$ Million), 2024 & 2034
Table 3: Global Biomarkers Market by Application (in US$ Million), 2024 & 2034
Table 4: Global Biomarkers Market by Indication (in US$ Million), 2024 & 2034
Table 5: Global Biomarkers Market by Region (in US$ Million), 2024 & 2034
Table 6: Europe Biomarkers Market by Country (in US$ Million), 2024 & 2034
Table 7: North America Biomarkers Market by Country (in US$ Million), 2024 & 2034
Table 8: Asia Pacific Biomarkers Market by Country (in US$ Million), 2024 & 2034
Table 9: Latin America Biomarkers Market by Country (in US$ Million), 2024 & 2034
Table 10: Middle East & Africa Biomarkers Market by Country (in US$ Million),